The presence of the Philadelphia (Ph') chromosome in bone marrow cells from patients with chronic myelogenous leukemia (CML) (1) is a nonrandom change that occurs in about 90% of all patients who have this disease (2) . Abnormalities involving C group chromosomes (X plus nos. 6 through 12) are frequently seen in patients with various hematologic disorders, but these abnormalities are generally considered to be highly variable or random (3, 4) . This impression is derived from studies in which conventional staining procedures are used that do not permit identification of individual chromosomes.
In the present study, individual C group chromosomes are identified by their banding pattern with the use of quinacrine fluorescence (5) . The cells that were analyzed had been obtained from 21 patients with various hematologic diseases. Consistent patterns of chromosomal abnormalities, seen in these patients, were confirmed by analysis of case reports from other laboratories.
MATERIALS AND METHODS
Patients Studied by Author. Twenty-one patients, who had an abnormality of a C group chromosome that was detected with conventional Giemsa stain, were selected for this study. The group consisted of six patients with CML in the acute phase, 10 patients with acute leukemia (AL), three patients with polycythemia vera (PV), and one patient each with refractory anemia and neutropenia.
Chromosomes were prepared from bone marrow cells as described (6) . Peripheral blood cells were cultured for 24 and 48 hr without phytohemagglutinin to obtain immature myeloid cells in division and for 72 hr with phytohemagglutinin to provide lymphocytes in division.
Cells in metaphase were stained with quinacrine mustard and were photographed with a Leitz photomicroscope equipped with Ploem epi-illumination (7) . The same cells, stained with Giemsa, were photographed either before or after quinacrine fluorescence. The duplicate photographs were used to identify the chromosomes according to the Paris nomenclature (8) .
Patients Studied by Others. Accurate karyotypes determined with banding techniques, either quinacrine or Giemsa, were available for an additional 29 patients who had some hematologic disorder and a C group aberration. Results for 23 of these patients from 13 laboratories were obtained from published reports (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) ; results for six patients came from personal communications by H. Van den Berghe, A. de la Chapelle, S. F. Pan, and C. C. Lin. These 29 patients included three with CML in the acute phase (9, 10), one with Ph' negative CML (11), 12 with AL (12) (13) (14) (15) (16) (17) (18) , four with PV (11, 19) , and nine with other disorders such as refractory anemia (with or without ring sideroblasts) (17, 20) , neutropenia (21) , and myelofibrosis (22) (23) (24) . RESULTS Patients Studied by Author. Gains of one or more C group chromosomes occurred in 15 patients, whereas loss of all or part of a C group chromosome occurred in six.
The results of the analysis of the chromosomes involved in the changes are summarized in (26, 27) . A no. 7 chromosome was missing in one male patient whose leukemic cells showed a hypodiploid number.
Abnormalities in the C group were found in the three patients with PV; one had an additional no. 8 and no. 9 chromosome, one had an extra no. 9 (28) , and the third had a deletion of no. 7 distal to 7q22 (29 Patients Studied by Others. Of the 29 patients studied in other laboratories, 22 had gained a C chromosome, six had lost one, and in one patient one C chromosome was gained and another was lost. The proportion of patients with chromosomal gains found in the author's laboratory was not significantly different from that in other laboratories (15/21 and 22/28, respectively). The combined results (Table 2) show a very highly significant excess of patients who have gained C chromosomes as compared with those who have lost a C chromosome.
Of the 23 patients (11, 15, 17, (19) (20) (21) who had additional chromosomes, 14 had gained a no. 8 and one had gained a no. 8 and lost an X chromosome (15) . An additional no. 9 was observed in seven patients (18, 19, 22, 23) , including two patients with PV who also had an extra no. 8. An extra no. 10 chromosome was seen in one patient (9) , and an extra no. 11 in another. The cells of one patient had an extra no. 12 chromosome, with the later addition of a no. 7 (10) . When chromosomal losses were present, four individuals had lost all or part of no. 7 (12) (13) (14) 24) , and one had lost a no. 9 (16) . The loss of an X chromosome in two patients was associated with the gain of a no. 8 in one of them (15) .
When additional chromosomes were present, no. 8 was the one most frequently observed by others (15 of 23 patients), as well as in the author's laboratory (13 of 15). When chromosomes were lost, no. 7 was the autosome most frequently affected. Since the results from both groups of patients were similar, they were combined in Table 2 . The data have been analyzed to determine whether the specific chromosomal changes are significantly different statistically from a random pattern. The probability that 28 of 38 chromosomal gains would involve the same chromosome (no. 8) is <0.00001. The pattern of gains of the other chromosomes was analyzed by elimination of those patients in whom a no. 8 alone or no. 8 and another chromosome were involved; this left 10 patients. The probability that six of 10 chromosome gains, not involving no. 8, would affect the same chromosome (no. 9) is 0.008. An analysis of the chromosomes lost reveals that the probability that at least seven of 12 of these would affect the same chromosome (no. 7) is 0.002.
DISCUSSION
Nonrandom changes affecting three C group chromosomes have been identified in this study. The addition of a no. 8 chromosome is the most frequent abnormality; an additional no. 9 is seen much less commonly but still occurs significantly There is no satisfactory explanation for the apparently identical karyotypes, i.e., +8, +9, -7, found in patients with leukemia and with nonleukemic disorders such as refractory anemia or neutropenia, although the latter group shows an increased potential for leukemic transformation. The frequent occurrence in hematologic disorders of abnormalities of chromosome 8, as an extra chromosome or in a translocation (26, 27, 30) , is perplexing. It is possible that the association is the result of the particular genes carried on this chromosome. The observations-that the gene for glutathione reductase may be located on chromosome 8 (31) and that a patient with refractory anemia and a +8 karyotype showed increased amounts of this enzyme (32) provide preliminary evidence to support this proposition. It is also possible, however, that chromosome no. 8 is the site of insertion or activation of a specific oncogenic virus or of other agents. The +8 karyotype may represent one step or one mutation in a twostep (33) or multiple-step (34) system of carcinogenesis.
It has been stated previously (3, 4) (38) . These cells tend to lose chromosomes; no. 8 is the one most frequently lost, no. 1 is next, and then no. 9 (39) . Patients with diseases of the lymphatic system, such as Burkitt's lymphoma, multiple myeloma, and ataxia-telangiectasia, have abnormalities of chromosome 14 (40) . On the basis of these data, it appears that only certain chromosomes are found to be abnormal, and that these chromosomes are affected in a variety of somatic mutations, some of which are associated with malignancy.
Chromosomal abnormalities have also been analyzed in experimental tumors in animals, and two important conclusions can be drawn from this work (Fig. 2) 
